Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,034 | 1,005 | 98.2% |
| Education | $252.56 | 8 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,931 | 139 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,200 | 66 | $0 (2024) |
| Novo Nordisk Inc | $883.91 | 77 | $0 (2024) |
| Lilly USA, LLC | $818.36 | 64 | $0 (2024) |
| Amgen Inc. | $760.66 | 50 | $0 (2024) |
| Astellas Pharma US Inc | $737.85 | 37 | $0 (2024) |
| Allergan, Inc. | $724.51 | 77 | $0 (2020) |
| PFIZER INC. | $709.99 | 67 | $0 (2024) |
| GlaxoSmithKline, LLC. | $622.35 | 43 | $0 (2024) |
| Merck Sharp & Dohme LLC | $592.32 | 46 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,239 | 124 | ABBVIE INC. ($519.27) |
| 2023 | $2,330 | 137 | ABBVIE INC. ($561.99) |
| 2022 | $1,770 | 128 | ABBVIE INC. ($310.03) |
| 2021 | $2,020 | 136 | AbbVie Inc. ($342.35) |
| 2020 | $920.68 | 67 | Allergan, Inc. ($201.40) |
| 2019 | $1,676 | 143 | AstraZeneca Pharmaceuticals LP ($169.63) |
| 2018 | $1,772 | 156 | Allergan Inc. ($206.30) |
| 2017 | $1,559 | 122 | Allergan Inc. ($196.63) |
All Payment Transactions
1,013 individual payment records from CMS Open Payments — Page 1 of 41
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Durable Pump | ||||||
| 12/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $10.36 | General |
| Category: Inflammation | ||||||
| 12/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.90 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: Bone Health | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $24.42 | General |
| Category: Cardiovascular | ||||||
| 12/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: Cardio-renal | ||||||
| 12/03/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: VACCINES | ||||||
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.04 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: Hematology | ||||||
| 11/22/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $3.61 | General |
| Category: Inflammation | ||||||
| 11/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/13/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: VACCINE | ||||||
| 11/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $4.16 | General |
| Category: Cardiology | ||||||
| 10/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: PAIN | ||||||
| 10/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $15.87 | General |
| Category: GI | ||||||
| 10/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/14/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Diabetes | ||||||
| 10/14/2024 | Biogen, Inc. | SPINRAZA (Biological) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Neurology | ||||||
| 10/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 10/02/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Bone Health | ||||||
| 10/01/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 552 | 911 | $151,563 | $59,190 |
| 2022 | 11 | 657 | 1,054 | $140,753 | $60,843 |
| 2021 | 14 | 687 | 1,071 | $161,067 | $70,365 |
| 2020 | 17 | 749 | 1,220 | $166,192 | $61,125 |
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 183 | 402 | $101,304 | $32,260 | 31.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 128 | 128 | $22,126 | $15,688 | 70.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 28 | 38 | $13,376 | $4,945 | 37.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 32 | $5,696 | $2,026 | 35.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 25 | 28 | $3,220 | $1,267 | 39.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 36 | 37 | $925.00 | $906.50 | 98.0% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 33 | 34 | $986.00 | $744.60 | 75.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 43 | 76 | $1,520 | $723.52 | 47.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 22 | 99 | $1,485 | $484.95 | 32.7% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 26 | 37 | $925.00 | $145.78 | 15.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 186 | 368 | $72,179 | $28,125 | 39.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 143 | 143 | $38,096 | $17,492 | 45.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 52 | 52 | $4,779 | $3,653 | 76.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 41 | 56 | $7,128 | $3,190 | 44.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 18 | 20 | $5,147 | $2,759 | 53.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 32 | 42 | $5,780 | $1,815 | 31.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 59 | 62 | $2,133 | $1,699 | 79.7% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 42 | 79 | $1,580 | $756.45 | 47.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 31 | 165 | $2,913 | $725.32 | 24.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 13 | 15 | $528.00 | $421.63 | 79.9% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2022 | 40 | 52 | $490.00 | $206.44 | 42.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 196 | 401 | $76,591 | $30,326 | 39.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 162 | 162 | $47,304 | $19,921 | 42.1% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 29 | 30 | $4,500 | $3,730 | 82.9% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2021 | 12 | 13 | $4,355 | $3,127 | 71.8% |
About Dennis Hamp, D. O
Dennis Hamp, D. O is a Family Medicine healthcare provider based in West Jordan, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568405397.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dennis Hamp, D. O has received a total of $14,286 in payments from pharmaceutical and medical device companies, with $2,239 received in 2024. These payments were reported across 1,013 transactions from 80 companies. The most common payment nature is "Food and Beverage" ($14,034).
As a Medicare-enrolled provider, Hamp has provided services to 2,645 Medicare beneficiaries, totaling 4,256 services with total Medicare billing of $251,523. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location West Jordan, UT
- Active Since 06/13/2006
- Last Updated 03/21/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1568405397
Products in Payments
- VRAYLAR (Drug) $1,241
- FARXIGA (Drug) $722.84
- UBRELVY (Drug) $578.59
- ELIQUIS (Drug) $526.26
- JARDIANCE (Drug) $482.44
- QULIPTA (Drug) $403.54
- Aimovig (Biological) $364.35
- TRULICITY (Drug) $305.29
- SHINGRIX (Biological) $296.80
- Ozempic (Drug) $239.27
- Kerendia (Drug) $234.77
- Trintellix (Drug) $234.56
- TOUJEO (Drug) $220.65
- Sunosi (Drug) $217.73
- TRELEGY ELLIPTA (Drug) $215.09
- NURTEC ODT (Drug) $192.11
- AIRSUPRA (Drug) $189.10
- MYRBETRIQ (Drug) $186.11
- Myrbetriq (Drug) $184.41
- REXULTI (Drug) $172.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in West Jordan
Judith Kirstein, M.d, M.D
Family Medicine — Payments: $20,575
Michael Sanderson, Md, MD
Family Medicine — Payments: $13,770
Preston Wilson, D.o, D.O
Family Medicine — Payments: $13,194
Peter Christensen, Md, MD
Family Medicine — Payments: $12,916
Brenten Pugh, M.d, M.D
Family Medicine — Payments: $10,976
Randall Fillmore, Md, MD
Family Medicine — Payments: $10,920